vs
Progyny, Inc.（PGNY）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Progyny, Inc.的季度营收约是Rocket Lab Corp的1.8倍（$318.4M vs $179.7M），Progyny, Inc.净利率更高（3.9% vs -29.5%，领先33.4%），Rocket Lab Corp同比增速更快（35.7% vs 6.7%），Progyny, Inc.自由现金流更多（$48.6M vs $-114.2M），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 7.0%）
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
PGNY vs RKLB — 直观对比
营收规模更大
PGNY
是对方的1.8倍
$179.7M
营收增速更快
RKLB
高出29.0%
6.7%
净利率更高
PGNY
高出33.4%
-29.5%
自由现金流更多
PGNY
多$162.8M
$-114.2M
两年增速更快
RKLB
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $318.4M | $179.7M |
| 净利润 | $12.5M | $-52.9M |
| 毛利率 | 24.1% | 38.0% |
| 营业利润率 | 4.8% | -28.4% |
| 净利率 | 3.9% | -29.5% |
| 营收同比 | 6.7% | 35.7% |
| 净利润同比 | 18.5% | -1.1% |
| 每股收益（稀释后） | $0.14 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PGNYRKLB
| Q4 25 | $318.4M | $179.7M | ||
| Q3 25 | $313.3M | $155.1M | ||
| Q2 25 | $332.9M | $144.5M | ||
| Q1 25 | $324.0M | $122.6M | ||
| Q4 24 | $298.4M | $132.4M | ||
| Q3 24 | $286.6M | $104.8M | ||
| Q2 24 | $304.1M | $106.3M | ||
| Q1 24 | $278.1M | $92.8M |
净利润PGNYRKLB
| Q4 25 | $12.5M | $-52.9M | ||
| Q3 25 | $13.9M | $-18.3M | ||
| Q2 25 | $17.1M | $-66.4M | ||
| Q1 25 | $15.1M | $-60.6M | ||
| Q4 24 | $10.5M | $-52.3M | ||
| Q3 24 | $10.4M | $-51.9M | ||
| Q2 24 | $16.5M | $-41.6M | ||
| Q1 24 | $16.9M | $-44.3M |
毛利率PGNYRKLB
| Q4 25 | 24.1% | 38.0% | ||
| Q3 25 | 23.2% | 37.0% | ||
| Q2 25 | 23.7% | 32.1% | ||
| Q1 25 | 23.4% | 28.8% | ||
| Q4 24 | 21.3% | 27.8% | ||
| Q3 24 | 20.7% | 26.7% | ||
| Q2 24 | 22.5% | 25.6% | ||
| Q1 24 | 22.4% | 26.1% |
营业利润率PGNYRKLB
| Q4 25 | 4.8% | -28.4% | ||
| Q3 25 | 6.9% | -38.0% | ||
| Q2 25 | 7.3% | -41.3% | ||
| Q1 25 | 7.5% | -48.3% | ||
| Q4 24 | 5.3% | -38.9% | ||
| Q3 24 | 4.3% | -49.5% | ||
| Q2 24 | 6.8% | -40.7% | ||
| Q1 24 | 6.7% | -46.4% |
净利率PGNYRKLB
| Q4 25 | 3.9% | -29.5% | ||
| Q3 25 | 4.4% | -11.8% | ||
| Q2 25 | 5.1% | -46.0% | ||
| Q1 25 | 4.6% | -49.5% | ||
| Q4 24 | 3.5% | -39.5% | ||
| Q3 24 | 3.6% | -49.6% | ||
| Q2 24 | 5.4% | -39.2% | ||
| Q1 24 | 6.1% | -47.7% |
每股收益（稀释后）PGNYRKLB
| Q4 25 | $0.14 | $-0.09 | ||
| Q3 25 | $0.15 | $-0.03 | ||
| Q2 25 | $0.19 | $-0.13 | ||
| Q1 25 | $0.17 | $-0.12 | ||
| Q4 24 | $0.12 | $-0.11 | ||
| Q3 24 | $0.11 | $-0.10 | ||
| Q2 24 | $0.17 | $-0.08 | ||
| Q1 24 | $0.17 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.2M | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $516.0M | $1.7B |
| 总资产 | $742.4M | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资PGNYRKLB
| Q4 25 | $112.2M | $1.0B | ||
| Q3 25 | $134.0M | $976.7M | ||
| Q2 25 | $132.5M | $688.1M | ||
| Q1 25 | $109.2M | $428.4M | ||
| Q4 24 | $162.3M | $419.0M | ||
| Q3 24 | $91.5M | $442.4M | ||
| Q2 24 | $95.0M | $496.8M | ||
| Q1 24 | $115.0M | $492.5M |
总债务PGNYRKLB
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M | ||
| Q1 24 | — | $66.8M |
股东权益PGNYRKLB
| Q4 25 | $516.0M | $1.7B | ||
| Q3 25 | $560.0M | $1.3B | ||
| Q2 25 | $515.0M | $688.5M | ||
| Q1 25 | $467.2M | $431.3M | ||
| Q4 24 | $422.1M | $382.5M | ||
| Q3 24 | $434.9M | $419.8M | ||
| Q2 24 | $456.2M | $455.2M | ||
| Q1 24 | $571.6M | $478.9M |
总资产PGNYRKLB
| Q4 25 | $742.4M | $2.3B | ||
| Q3 25 | $795.2M | $2.2B | ||
| Q2 25 | $761.0M | $1.6B | ||
| Q1 25 | $730.3M | $1.3B | ||
| Q4 24 | $607.1M | $1.2B | ||
| Q3 24 | $660.0M | $1.2B | ||
| Q2 24 | $698.6M | $1.2B | ||
| Q1 24 | $794.3M | $1.2B |
负债/权益比PGNYRKLB
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.2M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $48.6M | $-114.2M |
| 自由现金流率自由现金流/营收 | 15.3% | -63.6% |
| 资本支出强度资本支出/营收 | 1.8% | 27.6% |
| 现金转化率经营现金流/净利润 | 4.34× | — |
| 过去12个月自由现金流最近4个季度 | $191.8M | $-321.8M |
8季度趋势，按日历期对齐
经营现金流PGNYRKLB
| Q4 25 | $54.2M | $-64.5M | ||
| Q3 25 | $50.7M | $-23.5M | ||
| Q2 25 | $55.5M | $-23.2M | ||
| Q1 25 | $49.8M | $-54.2M | ||
| Q4 24 | $52.2M | $-2.4M | ||
| Q3 24 | $44.5M | $-30.9M | ||
| Q2 24 | $56.7M | $-13.0M | ||
| Q1 24 | $25.7M | $-2.6M |
自由现金流PGNYRKLB
| Q4 25 | $48.6M | $-114.2M | ||
| Q3 25 | $46.0M | $-69.4M | ||
| Q2 25 | $50.2M | $-55.3M | ||
| Q1 25 | $47.0M | $-82.9M | ||
| Q4 24 | $50.3M | $-23.9M | ||
| Q3 24 | $42.7M | $-41.9M | ||
| Q2 24 | $55.8M | $-28.3M | ||
| Q1 24 | $24.9M | $-21.8M |
自由现金流率PGNYRKLB
| Q4 25 | 15.3% | -63.6% | ||
| Q3 25 | 14.7% | -44.8% | ||
| Q2 25 | 15.1% | -38.3% | ||
| Q1 25 | 14.5% | -67.6% | ||
| Q4 24 | 16.8% | -18.1% | ||
| Q3 24 | 14.9% | -40.0% | ||
| Q2 24 | 18.4% | -26.7% | ||
| Q1 24 | 8.9% | -23.5% |
资本支出强度PGNYRKLB
| Q4 25 | 1.8% | 27.6% | ||
| Q3 25 | 1.5% | 29.6% | ||
| Q2 25 | 1.6% | 22.2% | ||
| Q1 25 | 0.9% | 23.4% | ||
| Q4 24 | 0.6% | 16.3% | ||
| Q3 24 | 0.6% | 10.5% | ||
| Q2 24 | 0.3% | 14.4% | ||
| Q1 24 | 0.3% | 20.7% |
现金转化率PGNYRKLB
| Q4 25 | 4.34× | — | ||
| Q3 25 | 3.65× | — | ||
| Q2 25 | 3.24× | — | ||
| Q1 25 | 3.31× | — | ||
| Q4 24 | 4.95× | — | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 1.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
